MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Bartter Disease Type 4B impacts kidney function due to BSND gene mutations. Clinical evaluation, lab tests, and genetic testing aid in accurate diagnosis and personalized…
Explore blepharophimosis, its symptoms, diagnosis, and the critical role genetic testing plays in identifying mutations, risk assessment, and personalized treatment plans.
Explore how genetic testing aids in diagnosing breast lobular carcinoma, understand its unique characteristics, and learn about personalized treatment plans and risk management.
Explore how genetic testing can diagnose and manage cardiac arrest. Learn about genetic mutations, family screening, and personalized treatments to save lives.
Centromeric instability of chromosomes 1, 9, and 16 causes immunodeficiency. Explore symptoms, genetic testing, and management of rare ICF syndrome.
Explore cerebellar ataxia symptoms, diagnosis, and the impact of genetic testing. Learn how genetic insights can optimize treatment and guide crucial family planning decisions.
Explore how genetic testing for CADASIL, a rare genetic brain disorder, aids in diagnosis, family planning, personalized treatment, and ongoing research efforts.
CCM diagnosis involves clinical evaluation, MRI, and genetic testing. Identifying CCM1, CCM2, or CCM3 mutations aids in treatment, family planning, and risk assessment.